# Safety and Efficacy of Etravirine in Friedreich Ataxia Patients

> **NCT04273165** · PHASE2 · COMPLETED · sponsor: **IRCCS Eugenio Medea** · enrollment: 30 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** Etravirine Tablets

## Key facts

- **NCT ID:** NCT04273165
- **Lead sponsor:** IRCCS Eugenio Medea
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-17
- **Primary completion:** 2023-01-17
- **Final completion:** 2023-01-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04273165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04273165, "Safety and Efficacy of Etravirine in Friedreich Ataxia Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04273165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*